
Xiaoming Liu
Examiner (ID: 709, Phone: (571)270-0384 , Office: P/2812 )
| Most Active Art Unit | 2812 |
| Art Unit(s) | 2812 |
| Total Applications | 629 |
| Issued Applications | 504 |
| Pending Applications | 79 |
| Abandoned Applications | 79 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7587390
[patent_doc_number] => 20110281900
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-17
[patent_title] => 'Crystalline Pharmaceutical'
[patent_app_type] => utility
[patent_app_number] => 13/107780
[patent_app_country] => US
[patent_app_date] => 2011-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 12115
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20110281900.pdf
[firstpage_image] =>[orig_patent_app_number] => 13107780
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/107780 | Crystalline pharmaceutical | May 12, 2011 | Issued |
Array
(
[id] => 9749479
[patent_doc_number] => 08840950
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-23
[patent_title] => 'Compositions of nutrition supplementation for nutritional deficiencies and method of use therefore'
[patent_app_type] => utility
[patent_app_number] => 13/105383
[patent_app_country] => US
[patent_app_date] => 2011-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 19
[patent_no_of_words] => 5314
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13105383
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/105383 | Compositions of nutrition supplementation for nutritional deficiencies and method of use therefore | May 10, 2011 | Issued |
Array
(
[id] => 5936042
[patent_doc_number] => 20110212139
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-01
[patent_title] => 'HIGH-DENSITY LIPOPROTEIN COATED MEDICAL DEVICES'
[patent_app_type] => utility
[patent_app_number] => 13/102791
[patent_app_country] => US
[patent_app_date] => 2011-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7803
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0212/20110212139.pdf
[firstpage_image] =>[orig_patent_app_number] => 13102791
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/102791 | High-density lipoprotein coated medical devices | May 5, 2011 | Issued |
Array
(
[id] => 7573024
[patent_doc_number] => 20110268680
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-03
[patent_title] => 'HEAT STABLE PROTEIN INGREDIENTS'
[patent_app_type] => utility
[patent_app_number] => 13/098694
[patent_app_country] => US
[patent_app_date] => 2011-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 64
[patent_figures_cnt] => 64
[patent_no_of_words] => 14127
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0268/20110268680.pdf
[firstpage_image] =>[orig_patent_app_number] => 13098694
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/098694 | Heat stable protein ingredients | May 1, 2011 | Issued |
Array
(
[id] => 6090358
[patent_doc_number] => 20110218148
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-08
[patent_title] => 'PHARMACEUTICAL COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 13/079400
[patent_app_country] => US
[patent_app_date] => 2011-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11547
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0218/20110218148.pdf
[firstpage_image] =>[orig_patent_app_number] => 13079400
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/079400 | PHARMACEUTICAL COMPOSITION | Apr 3, 2011 | Abandoned |
Array
(
[id] => 8128621
[patent_doc_number] => 20120088848
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-12
[patent_title] => 'METHODS AND COMPOSITIONS FOR CONTROLLED POLYPEPTIDE SYNTHESIS'
[patent_app_type] => utility
[patent_app_number] => 13/076953
[patent_app_country] => US
[patent_app_date] => 2011-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 36789
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20120088848.pdf
[firstpage_image] =>[orig_patent_app_number] => 13076953
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/076953 | METHODS AND COMPOSITIONS FOR CONTROLLED POLYPEPTIDE SYNTHESIS | Mar 30, 2011 | Abandoned |
Array
(
[id] => 7697084
[patent_doc_number] => 20110229506
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-22
[patent_title] => 'METHOD FOR CANCER IMMUNOTHERAPY'
[patent_app_type] => utility
[patent_app_number] => 13/053996
[patent_app_country] => US
[patent_app_date] => 2011-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13571
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20110229506.pdf
[firstpage_image] =>[orig_patent_app_number] => 13053996
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/053996 | Method for cancer immunotherapy | Mar 21, 2011 | Issued |
Array
(
[id] => 6102827
[patent_doc_number] => 20110166320
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-07
[patent_title] => 'SOMATOSTATIN ANALOGUES'
[patent_app_type] => utility
[patent_app_number] => 13/048935
[patent_app_country] => US
[patent_app_date] => 2011-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8545
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20110166320.pdf
[firstpage_image] =>[orig_patent_app_number] => 13048935
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/048935 | Somatostatin analogues | Mar 15, 2011 | Issued |
Array
(
[id] => 6189800
[patent_doc_number] => 20110172157
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-14
[patent_title] => 'SOMATOSTATIN ANALOGUES'
[patent_app_type] => utility
[patent_app_number] => 13/048932
[patent_app_country] => US
[patent_app_date] => 2011-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8547
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20110172157.pdf
[firstpage_image] =>[orig_patent_app_number] => 13048932
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/048932 | Somatostatin analogues | Mar 15, 2011 | Issued |
Array
(
[id] => 10110068
[patent_doc_number] => 09145472
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-29
[patent_title] => 'Charge reversible polymers'
[patent_app_type] => utility
[patent_app_number] => 13/033247
[patent_app_country] => US
[patent_app_date] => 2011-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 20
[patent_no_of_words] => 6806
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13033247
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/033247 | Charge reversible polymers | Feb 22, 2011 | Issued |
Array
(
[id] => 7663609
[patent_doc_number] => 20110312878
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-22
[patent_title] => 'PHARMACOLOGICALLY ACTIVE PEPTIDE CONJUGATES HAVING A REDUCED TENDENCY TOWARDS ENZYMATIC HYDROLYSIS'
[patent_app_type] => utility
[patent_app_number] => 13/027475
[patent_app_country] => US
[patent_app_date] => 2011-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31051
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20110312878.pdf
[firstpage_image] =>[orig_patent_app_number] => 13027475
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/027475 | PHARMACOLOGICALLY ACTIVE PEPTIDE CONJUGATES HAVING A REDUCED TENDENCY TOWARDS ENZYMATIC HYDROLYSIS | Feb 14, 2011 | Abandoned |
Array
(
[id] => 9427835
[patent_doc_number] => 08703912
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-22
[patent_title] => 'Processes for removal of dibenzofulvene'
[patent_app_type] => utility
[patent_app_number] => 13/020838
[patent_app_country] => US
[patent_app_date] => 2011-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14065
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13020838
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/020838 | Processes for removal of dibenzofulvene | Feb 3, 2011 | Issued |
Array
(
[id] => 6002807
[patent_doc_number] => 20110118179
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-19
[patent_title] => 'CATION COMPLEXES OF INSULIN COMPOUND CONJUGATES, FORMULATIONS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/012146
[patent_app_country] => US
[patent_app_date] => 2011-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 43
[patent_no_of_words] => 57251
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20110118179.pdf
[firstpage_image] =>[orig_patent_app_number] => 13012146
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/012146 | Cation complexes of insulin compound conjugates, formulations and uses thereof | Jan 23, 2011 | Issued |
Array
(
[id] => 6186190
[patent_doc_number] => 20110124553
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-26
[patent_title] => 'INSULIN-OLIGOMER CONJUGATES, FORMULATIONS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/008094
[patent_app_country] => US
[patent_app_date] => 2011-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 43
[patent_no_of_words] => 57027
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20110124553.pdf
[firstpage_image] =>[orig_patent_app_number] => 13008094
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/008094 | Insulin-oligomer conjugates, formulations and uses thereof | Jan 17, 2011 | Issued |
Array
(
[id] => 6187755
[patent_doc_number] => 20110171196
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-14
[patent_title] => 'METHODS OF TREATMENT AND USES FOR CAMKII AND ITS INTERACTION WITH HDACS AND CALPAIN'
[patent_app_type] => utility
[patent_app_number] => 12/984421
[patent_app_country] => US
[patent_app_date] => 2011-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 21155
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20110171196.pdf
[firstpage_image] =>[orig_patent_app_number] => 12984421
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/984421 | METHODS OF TREATMENT AND USES FOR CAMKII AND ITS INTERACTION WITH HDACS AND CALPAIN | Jan 3, 2011 | Abandoned |
Array
(
[id] => 5968970
[patent_doc_number] => 20110150837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-23
[patent_title] => 'Amphiphilic polymer functionalized by methionine'
[patent_app_type] => utility
[patent_app_number] => 12/977816
[patent_app_country] => US
[patent_app_date] => 2010-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6030
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0150/20110150837.pdf
[firstpage_image] =>[orig_patent_app_number] => 12977816
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/977816 | Amphiphilic polymer functionalized by methionine | Dec 22, 2010 | Abandoned |
Array
(
[id] => 6000611
[patent_doc_number] => 20110117057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-19
[patent_title] => 'NOVEL PEPTIDES AS NS3-SERINE PROTEASE INHIBITORS OF HEPATITIS C VIRUS'
[patent_app_type] => utility
[patent_app_number] => 12/973020
[patent_app_country] => US
[patent_app_date] => 2010-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37463
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0117/20110117057.pdf
[firstpage_image] =>[orig_patent_app_number] => 12973020
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/973020 | NOVEL PEPTIDES AS NS3-SERINE PROTEASE INHIBITORS OF HEPATITIS C VIRUS | Dec 19, 2010 | Abandoned |
Array
(
[id] => 5972495
[patent_doc_number] => 20110152188
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-23
[patent_title] => 'PHARMACEUTICAL COMPOSITIONS OF IGF/I PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 12/969619
[patent_app_country] => US
[patent_app_date] => 2010-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7918
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20110152188.pdf
[firstpage_image] =>[orig_patent_app_number] => 12969619
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/969619 | PHARMACEUTICAL COMPOSITIONS OF IGF/I PROTEINS | Dec 15, 2010 | Abandoned |
Array
(
[id] => 6083598
[patent_doc_number] => 20110144014
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-16
[patent_title] => 'CYTOKINE RECEPTOR MODULATORS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/968363
[patent_app_country] => US
[patent_app_date] => 2010-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 54
[patent_figures_cnt] => 54
[patent_no_of_words] => 44922
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0144/20110144014.pdf
[firstpage_image] =>[orig_patent_app_number] => 12968363
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/968363 | CYTOKINE RECEPTOR MODULATORS AND USES THEREOF | Dec 14, 2010 | Abandoned |
Array
(
[id] => 5944781
[patent_doc_number] => 20110105401
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-05
[patent_title] => 'PEPTIDE COMPOSITION AND A METHOD OF PROMOTING CARTILAGE FORMATION'
[patent_app_type] => utility
[patent_app_number] => 12/968532
[patent_app_country] => US
[patent_app_date] => 2010-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 17175
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20110105401.pdf
[firstpage_image] =>[orig_patent_app_number] => 12968532
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/968532 | Peptide composition and a method of promoting cartilage formation | Dec 14, 2010 | Issued |